Significant Post-Chemotherapy Decrease of Ovarian Reserve in Iranian Women With Breast Cancer Publisher



Eslami B¹ ; Jalaeefar A² ; Moini A^{1, 3, 4} ; Omranipour R^{1, 2} ; Haghighi M⁵ ; Alipour S^{1, 6} Show Affiliations
Source: Acta Medica Iranica Published:2020

Abstract

Fertility preservation counseling has a high priority in young breast cancer (BC) patients. Cytotoxic chemicals used for chemotherapy in these patients increased the risk of premature ovarian failure. This study evaluated the anti-mullerian hormone (AMH) level at the time of diagnosis and within a month after the end of chemotherapy, while predicting the time of the return of ovarian function in BC cases (n=46) younger than 46 years for the first time in Iran. Cases were selected from those attending the breast oncology clinic of the two hospitals with a newly diagnosed in situ or invasive BC. The present study results showed AMH levels were significantly decreased in almost all women within a month after chemotherapy. It seems that the need for fertility preservation depends on patient age and baseline AMH level, but counseling should be offered by the clinician in young breast cancer patients. © 2020 Tehran University of Medical Sciences. All rights reserved.